Jeffrey Milbrandt

Mallinckrodt (United States)

Papers

1

Total Citations

69

H-Index

1

About

Jeffrey Milbrandt is a pioneering neuroscientist whose research has fundamentally reshaped our understanding of axon degeneration and neuronal survival. His work bridges molecular genetics, cellular biology, and high-throughput screening to uncover the mechanisms underlying peripheral neuropathies and neurodegenerative diseases. In a landmark 2011 study, Milbrandt and his team combined robotic liquid handling with automated microscopy to perform an image-based screen, revealing novel roles for IκB kinase and glycogen synthase kinase 3 in the active, self-destruction program of compromised axons. This work, cited over 69 times, demonstrated that axon degeneration is not a passive process but an evolutionarily conserved pathway distinct from programmed cell death. Beyond this, Milbrandt’s contributions extend to identifying key genetic regulators of myelin formation and neuronal metabolism, with his research accumulating thousands of citations. His innovative use of unbiased screening approaches has provided critical insights into potential therapeutic targets for conditions like Charcot-Marie-Tooth disease and spinal cord injury. A member of the National Academy of Sciences, Milbrandt continues to lead efforts in understanding how neurons respond to stress, making his work essential reading for students and researchers exploring the frontiers of neurobiology and translational medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
69
Total Citations
69
Avg Citations/Paper
🏆 Most Cited Paper
Image-based Screening Identifies Novel Roles for IκB Kinase and Glycogen Synthase Kinase 3 in Axonal Degeneration
69 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Mallinckrodt (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago